Report Detail

Pharma & Healthcare Global Milbexime Anthelmintic Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4556775
  • |
  • 17 September, 2023
  • |
  • Global
  • |
  • 98 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Milbexime Anthelmintic market size was valued at USD 646.2 million in 2022 and is forecast to a readjusted size of USD 949.1 million by 2029 with a CAGR of 5.6% during review period.
Similar to other macrolide antiparasitic drugs, milbexime acts as an agonist of GABA (γ-aminobutyric acid) neurotransmitter in nerve cells, and can also interact with gluten in nerve and muscle cells of invertebrates Amino acid-gated Cl-channel binding. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die. Milbexime also affects the reproductive activity of some parasites by reducing oviposition or inducing abnormal egg production.
The Global Info Research report includes an overview of the development of the Milbexime Anthelmintic industry chain, the market status of Cat (Single Ingredient, Compound Ingredients), Dog (Single Ingredient, Compound Ingredients), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Milbexime Anthelmintic.
Regionally, the report analyzes the Milbexime Anthelmintic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Milbexime Anthelmintic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Milbexime Anthelmintic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Milbexime Anthelmintic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Single Ingredient, Compound Ingredients).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Milbexime Anthelmintic market.
Regional Analysis: The report involves examining the Milbexime Anthelmintic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Milbexime Anthelmintic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Milbexime Anthelmintic:
Company Analysis: Report covers individual Milbexime Anthelmintic manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Milbexime Anthelmintic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cat, Dog).
Technology Analysis: Report covers specific technologies relevant to Milbexime Anthelmintic. It assesses the current state, advancements, and potential future developments in Milbexime Anthelmintic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Milbexime Anthelmintic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Milbexime Anthelmintic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Single Ingredient
Compound Ingredients
Market segment by Application
Cat
Dog
Other
Major players covered
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
VIRBAC SA
Krka
Zhejiang Hisun Pharmaceutical Co., Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Milbexime Anthelmintic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Milbexime Anthelmintic, with price, sales, revenue and global market share of Milbexime Anthelmintic from 2018 to 2023.
Chapter 3, the Milbexime Anthelmintic competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Milbexime Anthelmintic breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Milbexime Anthelmintic market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Milbexime Anthelmintic.
Chapter 14 and 15, to describe Milbexime Anthelmintic sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Milbexime Anthelmintic
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Milbexime Anthelmintic Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Single Ingredient
    • 1.3.3 Compound Ingredients
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Milbexime Anthelmintic Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Cat
    • 1.4.3 Dog
    • 1.4.4 Other
  • 1.5 Global Milbexime Anthelmintic Market Size & Forecast
    • 1.5.1 Global Milbexime Anthelmintic Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Milbexime Anthelmintic Sales Quantity (2018-2029)
    • 1.5.3 Global Milbexime Anthelmintic Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Elanco Animal Health
    • 2.1.1 Elanco Animal Health Details
    • 2.1.2 Elanco Animal Health Major Business
    • 2.1.3 Elanco Animal Health Milbexime Anthelmintic Product and Services
    • 2.1.4 Elanco Animal Health Milbexime Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Elanco Animal Health Recent Developments/Updates
  • 2.2 Boehringer Ingelheim Animal Health
    • 2.2.1 Boehringer Ingelheim Animal Health Details
    • 2.2.2 Boehringer Ingelheim Animal Health Major Business
    • 2.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product and Services
    • 2.2.4 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
  • 2.3 Merck Animal Health
    • 2.3.1 Merck Animal Health Details
    • 2.3.2 Merck Animal Health Major Business
    • 2.3.3 Merck Animal Health Milbexime Anthelmintic Product and Services
    • 2.3.4 Merck Animal Health Milbexime Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Merck Animal Health Recent Developments/Updates
  • 2.4 VIRBAC SA
    • 2.4.1 VIRBAC SA Details
    • 2.4.2 VIRBAC SA Major Business
    • 2.4.3 VIRBAC SA Milbexime Anthelmintic Product and Services
    • 2.4.4 VIRBAC SA Milbexime Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 VIRBAC SA Recent Developments/Updates
  • 2.5 Krka
    • 2.5.1 Krka Details
    • 2.5.2 Krka Major Business
    • 2.5.3 Krka Milbexime Anthelmintic Product and Services
    • 2.5.4 Krka Milbexime Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Krka Recent Developments/Updates
  • 2.6 Zhejiang Hisun Pharmaceutical Co., Ltd
    • 2.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Details
    • 2.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Major Business
    • 2.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product and Services
    • 2.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates

3 Competitive Environment: Milbexime Anthelmintic by Manufacturer

  • 3.1 Global Milbexime Anthelmintic Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Milbexime Anthelmintic Revenue by Manufacturer (2018-2023)
  • 3.3 Global Milbexime Anthelmintic Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Milbexime Anthelmintic by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Milbexime Anthelmintic Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Milbexime Anthelmintic Manufacturer Market Share in 2022
  • 3.5 Milbexime Anthelmintic Market: Overall Company Footprint Analysis
    • 3.5.1 Milbexime Anthelmintic Market: Region Footprint
    • 3.5.2 Milbexime Anthelmintic Market: Company Product Type Footprint
    • 3.5.3 Milbexime Anthelmintic Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Milbexime Anthelmintic Market Size by Region
    • 4.1.1 Global Milbexime Anthelmintic Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Milbexime Anthelmintic Consumption Value by Region (2018-2029)
    • 4.1.3 Global Milbexime Anthelmintic Average Price by Region (2018-2029)
  • 4.2 North America Milbexime Anthelmintic Consumption Value (2018-2029)
  • 4.3 Europe Milbexime Anthelmintic Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Milbexime Anthelmintic Consumption Value (2018-2029)
  • 4.5 South America Milbexime Anthelmintic Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Milbexime Anthelmintic Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Milbexime Anthelmintic Sales Quantity by Type (2018-2029)
  • 5.2 Global Milbexime Anthelmintic Consumption Value by Type (2018-2029)
  • 5.3 Global Milbexime Anthelmintic Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Milbexime Anthelmintic Sales Quantity by Application (2018-2029)
  • 6.2 Global Milbexime Anthelmintic Consumption Value by Application (2018-2029)
  • 6.3 Global Milbexime Anthelmintic Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Milbexime Anthelmintic Sales Quantity by Type (2018-2029)
  • 7.2 North America Milbexime Anthelmintic Sales Quantity by Application (2018-2029)
  • 7.3 North America Milbexime Anthelmintic Market Size by Country
    • 7.3.1 North America Milbexime Anthelmintic Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Milbexime Anthelmintic Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Milbexime Anthelmintic Sales Quantity by Type (2018-2029)
  • 8.2 Europe Milbexime Anthelmintic Sales Quantity by Application (2018-2029)
  • 8.3 Europe Milbexime Anthelmintic Market Size by Country
    • 8.3.1 Europe Milbexime Anthelmintic Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Milbexime Anthelmintic Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Milbexime Anthelmintic Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Milbexime Anthelmintic Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Milbexime Anthelmintic Market Size by Region
    • 9.3.1 Asia-Pacific Milbexime Anthelmintic Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Milbexime Anthelmintic Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Milbexime Anthelmintic Sales Quantity by Type (2018-2029)
  • 10.2 South America Milbexime Anthelmintic Sales Quantity by Application (2018-2029)
  • 10.3 South America Milbexime Anthelmintic Market Size by Country
    • 10.3.1 South America Milbexime Anthelmintic Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Milbexime Anthelmintic Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Milbexime Anthelmintic Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Milbexime Anthelmintic Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Milbexime Anthelmintic Market Size by Country
    • 11.3.1 Middle East & Africa Milbexime Anthelmintic Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Milbexime Anthelmintic Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Milbexime Anthelmintic Market Drivers
  • 12.2 Milbexime Anthelmintic Market Restraints
  • 12.3 Milbexime Anthelmintic Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Milbexime Anthelmintic and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Milbexime Anthelmintic
  • 13.3 Milbexime Anthelmintic Production Process
  • 13.4 Milbexime Anthelmintic Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Milbexime Anthelmintic Typical Distributors
  • 14.3 Milbexime Anthelmintic Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Milbexime Anthelmintic. Industry analysis & Market Report on Milbexime Anthelmintic is a syndicated market report, published as Global Milbexime Anthelmintic Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Milbexime Anthelmintic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report